-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation